Trials / Completed
CompletedNCT00834366
A Study to Compare the Relative Bioavailability of Two 200 Mg Tramadol Hydrochloride Tablet Products Under Fasting Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 26 (actual)
- Sponsor
- Labopharm Inc. · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
To determine whether the test product, Labopharm Tramadol HCl Once-A-Day (OAD) 200 mg film-coated tablets, and the reference product, Labopharm Tramadol HCl OAD 200 mg uncoated tablets, are bioequivalent.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tramadol HCl | Single oral administration in fasting conditions of 1x200mg Tramadol HCl 200 mg Film-coated Tablet or Tramadol HCl 200 mg Uncoated Tablets based on randomization schedule. |
Timeline
- Start date
- 2005-02-01
- Primary completion
- 2005-03-01
- Completion
- 2005-03-01
- First posted
- 2009-02-03
- Last updated
- 2012-04-30
- Results posted
- 2009-06-08
Source: ClinicalTrials.gov record NCT00834366. Inclusion in this directory is not an endorsement.